Multi-Agent Automation of Global Literature and Medical Journal Surveillance

This agent operates on a scheduled crawl, programmatically accessing PubMed, EMBASE, Crossref, and preprint servers via their APIs. It uses targeted search queries built from the company's product portfolio (including drug names, synonyms, and mechanism of action) and relevant MedDRA Preferred Terms. The agent handles pagination, respects API rate limits, and deposits raw article metadata and abstracts into a secure ingestion queue. It is the foundational component that ensures comprehensive, continuous coverage of the global literature corpus.

For each ingested article, this LLM-powered agent performs a multi-step extraction: it identifies mentions of the company's products (disambiguating between trade and generic names), extracts described adverse events, and links patient demographics and outcomes. Crucially, it normalizes the extracted verbatim terms to candidate MedDRA LLTs and PTs, and drug names to WHO-DD codes, generating a structured data payload with confidence scores. Low-confidence extractions are flagged for human review in a dedicated correction queue before proceeding.

This agent applies business logic to rank and route extracted events. It evaluates factors like: seriousness of the event (hospitalization, death), novelty (comparison against the reference safety information), number of cases in the article, and source journal impact. Using a configurable scoring model, it assigns a priority level (Critical, High, Medium, Low) and determines the appropriate destination—either creating a draft ICSR in the safety database (e.g., Veeva Safety, Oracle Argus) for high-priority signals or logging it for aggregate review in the periodic signal detection packet.

The central nervous system of the workflow. A LangGraph supervisor coordinates the handoffs between agents, manages state (e.g., article_ingested -> entities_extracted -> signal_scored), and handles exceptions. It enforces approval gates—for example, pausing the workflow to require a PV associate's sign-off before a draft ICSR is created from a high-priority but novel signal. This layer provides full auditability, enables conditional branching, and allows for hot-swapping agents or logic without disrupting the entire pipeline.

This component manages the bidirectional integration between the AI workflow and enterprise systems. For high-priority signals, it uses the safety database's REST API or a middleware layer to create a draft case with populated fields (drug, event, patient, literature source). It also ingests feedback loops: when a PV reviewer amends or confirms an AI-suggested MedDRA code in the safety database, that correction is fed back to improve the extraction agent's models. Additional integrations push summarized findings to signal management platforms and regulatory intelligence systems.

A dedicated web interface for PV associates and medical reviewers. It displays queues for: 1) Low-confidence extractions requiring validation, 2) High-priority signal proposals needing approval for case creation, and 3) Aggregate trend dashboards. The console provides side-by-side views of the source article and AI-extracted data, one-click approval/rejection actions, and override fields. All interactions are logged with user, timestamp, and rationale, creating a defensible audit trail for regulatory inspection. This console is the critical control plane for the automated system.

This workflow automates the manual, full-time equivalent (FTE) effort required to scan thousands of global publications monthly. The primary savings come from eliminating repetitive search, download, and initial screening tasks, allowing your medical reviewers to focus on high-signal assessment. A well-architected system can reduce literature review cycle time by 60-80%, compress signal detection windows from weeks to days, and significantly lower the risk of missed reports during regulatory inspections.

The build centers on a multi-agent orchestration layer (e.g., LangGraph) that manages a pipeline of specialized agents: Crawler Agents (schedule & fetch from PubMed, EMBASE, preprint servers), Extraction Agents (use LLMs with RAG over MedDRA/WHO-DD to identify AE mentions, drug names, and patient details), and Normalization Agents (link findings to your specific product portfolio and standard terminologies). A Confidence Scoring & Triage Agent then routes high-likelihood signals directly into your safety database (e.g., ARISg, Veeva Safety) for case processing, while flagging low-confidence items for human review.

Success depends on seamless integration with your existing tech stack. Key connections include:

• Safety Database API: For creating draft cases or safety information records from agent outputs.
• Identity & Access Management (IAM): For secure, auditable agent access to subscription-based literature repositories.
• Document Management System (e.g., Veeva Vault): For storing source PDFs and agent-generated extracts with full traceability.
• MedDRA/WHO-DD Services: For real-time terminology validation and coding suggestions during the extraction phase.
• Alerting & Dashboard Systems: To notify safety associates of new high-priority signals and provide operational metrics.

A phased rollout mitigates risk and demonstrates value incrementally.

1. Phase 1: Core Pipeline for a Single Source: Build and validate the agent pipeline for one high-value source (e.g., PubMed) for a single product, focusing on extraction accuracy and integration with your safety database's test environment.
2. Phase 2: Scale Sources & Add Triage Logic: Add additional literature sources (EMBASE, key journals) and implement the confidence scoring and automated routing logic.
3. Phase 3: Expand Product Portfolio & Operational Handoff: Scale the system to monitor your full product portfolio, finalize operational procedures (review queues, exception handling), and transition to a production support model. A focused 8-12 week pilot for 1-2 products is typical to prove technical and operational viability.

Automation in a GxP-adjacent area requires built-in controls. Your architecture must include:

• Human-in-the-Loop Gates: Mandatory medical review of all agent-proposed signals before database entry; a clear queue for reviewing low-confidence extractions.
• Explainability & Audit Trails: Every agent action and decision (e.g., why a paper was flagged, which MedDRA code was suggested and why) must be logged in an immutable audit trail.
• Performance Monitoring Dashboards: Track key metrics: papers processed vs. missed, extraction precision/recall, false positive rate, and end-to-end processing time.
• Change Control: Version control for agent logic, prompt templates, and source configurations to support validation and updates.

Early architectural choices will define long-term maintainability and performance.

• Orchestration Framework: LangGraph for complex stateful workflows vs. simpler task queues for linear pipelines.
• LLM Strategy: Balancing cost/performance with hosted APIs (OpenAI, Anthropic) vs. domain-tuned open-source models (for sensitive data).
• Data Pipeline Resilience: Designing for API rate limits, source format changes, and incomplete downloads with retry logic and dead-letter queues.
• Deployment Model: Containerized agents (Docker/Kubernetes) for scalability vs. serverless functions for event-driven components, integrated with your cloud or on-premise safety infrastructure.